Clinical Trials
4 trialsNCT03690869 2025-04-08
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Regeneron Pharmaceuticals
Phase 1/2 Terminated
NCT03126266 2024-12-05
Re-Irradiation of Progressive or Recurrent DIPG
University of Calgary
Phase NA Completed
NCT01469247 2022-10-20
Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03981068 2020-09-25
DAHANCA 37. Re-irradiation With Proton Radiotherapy
Danish Head and Neck Cancer Group
Phase NA Unknown